Arteris, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Arteris, Inc. on September 13, 2024. The report discloses a corporate governance event regarding the appointment of a new member to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the appointment of Joachim Kunkel to the Board of Directors, effective September 16, 2024. Mr. Kunkel was appointed as a Class II director and a member of the Compensation Committee. His term will expire at the 2026 annual meeting of stockholders or upon earlier resignation or removal.
Management Commentary and Compensation
Mr. Kunkel brings significant industry experience, having most recently served as General Manager of the Intellectual Property business unit at Synopsys, Inc., where he worked since 1994. Prior to Synopsys, he co-founded CADIS GmbH. Under the Company's non-employee director compensation program, Mr. Kunkel will receive:
- An annual retainer of $57,500, prorated for the remainder of 2024.
- An initial restricted stock unit (RSU) award valued at $300,000, calculated based on the 30-day average stock price on the grant date of September 16, 2024.
Mr. Kunkel has no relationships requiring disclosure under Item 404(a) of Regulation S-K and will enter into the Company's standard indemnification agreement.
Investor Verification Checklist
- Verify the effective date of Mr. Kunkel's board appointment (September 16, 2024).
- Confirm the specific share count of the RSU award once the 30-day average stock price is finalized.
- Review the Company's non-employee director compensation program (Exhibit 10.18 to Form S-1) for full terms.
- Check for any subsequent filings regarding Mr. Kunkel's committee assignments or potential conflicts of interest.